NDC 60793-136

SKELAXIN

Metaxalone

SKELAXIN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Metaxalone.

Product ID60793-136_5573f759-99ff-4cd4-a2b6-2c17bb25c519
NDC60793-136
Product TypeHuman Prescription Drug
Proprietary NameSKELAXIN
Generic NameMetaxalone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2002-08-30
Marketing CategoryNDA / NDA
Application NumberNDA013217
Labeler NamePfizer Laboratories Div Pfizer Inc
Substance NameMETAXALONE
Active Ingredient Strength800 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 60793-136-01

100 TABLET in 1 BOTTLE (60793-136-01)
Marketing Start Date2002-08-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 60793-136-01 [60793013601]

SKELAXIN TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-08-30

NDC 60793-136-05 [60793013605]

SKELAXIN TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-08-30

Drug Details

Active Ingredients

IngredientStrength
METAXALONE800 mg/1

OpenFDA Data

SPL SET ID:7a4163f2-c553-4d14-7e98-d14c5c7f772a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 352277
  • 351254

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Centrally-mediated Muscle Relaxation [PE]

    Medicade Reported Pricing

    60793013605 SKELAXIN 800 MG TABLET

    Pricing Unit: EA | Drug Type:

    60793013601 SKELAXIN 800 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "SKELAXIN" or generic name "Metaxalone"

    NDCBrand NameGeneric Name
    10544-524SKELAXINmetaxalone
    21695-123SkelaxinMetaxalone
    68788-0881SkelaxinSkelaxin
    55289-736SKELAXINSKELAXIN
    60793-136SKELAXINSKELAXIN
    80425-0084SkelaxinSkelaxin
    80425-0122SkelaxinSkelaxin
    0115-1745MetaxaloneMetaxalone
    0115-1748MetaxaloneMetaxalone
    0185-0448MetaxaloneMetaxalone
    0276-0508MetaxaloneMetaxalone
    0527-1435MetaxaloneMetaxalone
    0591-2341MetaxaloneMetaxalone
    0904-6831MetaxaloneMetaxalone
    10544-002MetaxaloneMetaxalone
    10544-144MetaxaloneMetaxalone
    21695-585MetaxaloneMetaxalone
    33261-724MetaxaloneMetaxalone
    35356-570MetaxaloneMetaxalone
    42254-040MetaxaloneMetaxalone
    42291-587MetaxaloneMetaxalone
    43063-239MetaxaloneMetaxalone
    43063-581MetaxaloneMetaxalone
    45865-942MetaxaloneMetaxalone
    45865-985MetaxaloneMetaxalone
    50090-1182MetaxaloneMetaxalone
    50090-3174MetaxaloneMetaxalone
    50090-3297MetaxaloneMetaxalone
    50090-3650MetaxaloneMetaxalone
    50090-3670MetaxaloneMetaxalone

    Trademark Results [SKELAXIN]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    SKELAXIN
    SKELAXIN
    72111057 0715343 Live/Registered
    A. H. Robins Company, Incorporated
    1960-12-30
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.